CDT Equity Amends Bylaws, Modifies Shareholder Rights
Ticker: CDT · Form: 8-K · Filed: Mar 25, 2026 · CIK: 0001896212
| Field | Detail |
|---|---|
| Company | Cdt Equity Inc. (CDT) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2026 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | mixed |
Complexity: moderate
Sentiment: mixed
Topics: corporate-governance, bylaw-amendment, shareholder-rights, regulation-fd
TL;DR
**CDT Equity just changed its bylaws and shareholder rights, so check the details ASAP!**
AI Summary
CDT Equity Inc. filed an 8-K on March 25, 2026, reporting material modifications to the rights of security holders and amendments to its Articles of Incorporation or Bylaws, effective March 24, 2026. This filing, under Items 3.03 and 5.03, indicates potential changes that could impact shareholder voting power, dividend rights, or other fundamental aspects of owning CDT Equity stock. Investors should review the specific exhibits (EX-3.1 and EX-99.1) to understand how these changes might affect their investment.
Why It Matters
Changes to bylaws and security holder rights can directly alter the value and control an investor has over their shares, potentially impacting future returns or corporate governance.
Risk Assessment
Risk Level: medium — Modifications to security holder rights and corporate bylaws can significantly impact an investor's position, making this a medium risk event until the specific changes are understood.
Analyst Insight
A smart investor would immediately review the EX-3.1 and EX-99.1 exhibits linked in the filing to understand the precise nature of the modifications to security holder rights and bylaws, as these could directly impact their investment's value or control.
Key Players & Entities
- CDT Equity Inc. (company) — the filer of the 8-K
- 0001896212 (company) — CDT Equity Inc.'s CIK
- 2026-03-25 (date) — filing and acceptance date of the 8-K
- 2026-03-24 (date) — period of report for the 8-K
Forward-Looking Statements
- CDT Equity Inc. will release further details on the specific bylaw amendments and security holder right modifications. (CDT Equity Inc.) — high confidence, target: 2026-04-25
FAQ
What specific items were reported in CDT Equity Inc.'s 8-K filing on March 25, 2026?
The 8-K filing by CDT Equity Inc. on March 25, 2026, reported under Item 3.03: Material Modifications to Rights of Security Holders, Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Item 7.01: Regulation FD Disclosure, and Item 9.01: Financial Statements and Exhibits.
What is the CIK number for CDT Equity Inc. as stated in the filing?
The CIK number for CDT Equity Inc. is 0001896212, as indicated in the filing.
When was the 8-K filing by CDT Equity Inc. accepted by the SEC?
The 8-K filing by CDT Equity Inc. was accepted by the SEC on 2026-03-25 at 08:15:25.
What type of business does CDT Equity Inc. primarily engage in, according to its SIC code?
According to its SIC code 2834, CDT Equity Inc. primarily engages in 'Pharmaceutical Preparations'.
Which exhibits are included in this 8-K filing that might detail the changes to security holder rights or bylaws?
The filing includes EX-3.1 (ex3-1.htm) and EX-99.1 (ex99-1.htm), which are likely to contain the details regarding the material modifications to rights of security holders and amendments to Articles of Incorporation or Bylaws.
Filing Stats: 1,114 words · 4 min read · ~4 pages · Grade level 10.8 · Accepted 2026-03-25 08:15:25
Key Financial Figures
- $0.0001 — ge on which registered Common Stock, $0.0001 par value per share CDT The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 51KB
- ex3-1.htm (EX-3.1) — 14KB
- ex99-1.htm (EX-99.1) — 13KB
- 0001493152-26-012538.txt ( ) — 297KB
- cdt-20260324.xsd (EX-101.SCH) — 4KB
- cdt-20260324_def.xml (EX-101.DEF) — 26KB
- cdt-20260324_lab.xml (EX-101.LAB) — 36KB
- cdt-20260324_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CDT EQUITY INC. March 25, 2026 By: /s/ Andrew Regan Name: Andrew Regan Title: Chief Executive Officer